Results 211 to 220 of about 11,037,570 (334)
This study integrates transcriptomic profiling of matched tumor and healthy tissues from 32 colorectal cancer patients with functional validation in patient‐derived organoids, revealing dysregulated metabolic programs driven by overexpressed xCT (SLC7A11) and SLC3A2, identifying an oncogenic cystine/glutamate transporter signature linked to ...
Marco Strecker +16 more
wiley +1 more source
Extended Endarterectomy Across the Inguinal Ligament Using Inguinal-Lifting in the Surgery for Critical Limb Ischemia. [PDF]
Tsuji A +7 more
europepmc +1 more source
The Effect of HARQ Procedure on the Performance of LTE System [PDF]
Firas S. Alsharbaty, Safwan H. Fasola
openalex +1 more source
This study characterizes the responses of primary acute myeloid leukemia (AML) patient samples to the MCL‐1 inhibitor MIK665. The results revealed that monocytic differentiation is associated with MIK665 sensitivity. Conversely, elevated ABCB1 expression is a potential biomarker of resistance to the treatment, which can be overcome by the combination ...
Joseph Saad +17 more
wiley +1 more source
Low invasive surfactant administration by videolaringoscopy: a feasibility study. [PDF]
Petrillo F +7 more
europepmc +1 more source
A new procedure to assess the hot rolling work roll materials [PDF]
J. Malbrancke +2 more
openalex +1 more source
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande +11 more
wiley +1 more source
Radiological procedures in gastrointestinal bleeding - treatment [PDF]
G. Layer
openalex +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source

